Skip to content
Head to head

Bio-Rad Laboratories vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: BIO · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

BIO +18.0%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield.
BIOABT
Snapshot
SectorMedical DevicesMedical Devices
Last price358.90103.00
Change today-2.34%-0.84%
1-year return+18.2%-15.4%
Market cap$9.65B$178.39B
52-week range236.73 – 396.2380.89 – 126.70
Valuation
P/E (TTM)9.5438.29
P/E percentile, own 5-yr range81st99th
P/B1.273.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)27.853.72
Net profit (TTM)$748.97M$6.44B
Revenue (TTM)$2.59B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+0.5%+14.5%
Gross margin51.3%56.9%
Operating margin6.2%13.8%
Net margin39.5%9.7%
Free cash flow (TTM)$329.10M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership88.7%81.2%
Insider activity (12mo)29 buy / 21 sell36 buy / 12 sell
Short interest (% of float)4.3%1.1%
Analyst consensus100% buy (1)93% buy / 7% hold (15)
Analyst price target$440 (+23%)$122 (+18%)
StockVane view
StockVane Quant RatingC (62)D (22)
Company
Employees7,450115,000
Founded19521900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.